Home/Pipeline/ORX489

ORX489

Neuropsychiatric Disorders

Pre-clinicalActive

Key Facts

Indication
Neuropsychiatric Disorders
Phase
Pre-clinical
Status
Active
Company

About Centessa Pharmaceuticals

Centessa Pharmaceuticals is a clinical-stage biotech company with a mission to discover and develop transformational medicines for patients. Its core strategy revolves around a portfolio of orexin receptor 2 agonist programs, led by ORX750, targeting significant unmet needs in sleep-wake disorders and broader neuroscience indications. The company is led by a seasoned team of industry veterans and operates with a lean, asset-focused development model to drive programs from discovery to late-stage development efficiently.

View full company profile

Other Neuropsychiatric Disorders Drugs

DrugCompanyPhase
Seaport Therapeutics ProgramsPureTech HealthNot Specified